Skip to main content
. 2013 Jul 18;4(10):1582–1591. doi: 10.18632/oncotarget.1050

Table 2. Drug transporter SNPs associated with CI-MMR at 18 months.

SNP Chr. Coordinate Transporter gene symbol SLEC SVC (P-value)
P-value FDR All 400 mg/d 600 mg/d
rs609468 6 160498904 SLC22A1 <0.001 0.001 0.920 0.210 0.090
rs10841907 12 21942563 ABCC9 0.001 0.238 0.310 0.670 0.450
rs12505410 4 89249865 ABCG2 0.002 0.238 0.045* 0.035* 0.320
rs4149182 11 62524689 SLC22A8 0.002 0.238 0.750 0.640 0.820
rs1189451 13 94520087 ABCC4 0.005 0.430 0.260 0.360 0.330
rs17556915 14 69318111 SLC10A1 0.008 0.482 0.068 0.130 0.230
rs11024300 11 17452549 ABCC8 0.009 0.482 0.870 0.550 0.160
rs13120400 4 89252551 ABCG2 0.012 0.482 0.140 0.046* 0.740
rs2725252 4 89280934 ABCG2 0.012 0.482 0.086 0.047* 0.740
rs2665691 11 22327832 SLC17A6 0.012 0.482 0.075 0.110 0.360
rs1678405 13 94627682 ABCC4 0.014 0.482 0.710 0.850 0.370
rs1048099 11 17453092 ABCC8 0.014 0.482 0.950 0.220 0.150

Chr., chromosome; FDR, false discover rate; SNP, single nucleotide polymorphism

*

Significant association between CI-MMR and SNP (P < 0.05)